Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma

Abstract Stomach adenocarcinoma (STAD) is the most prevalent gastrointestinal malignancy and seriously threatens the life of the global population. Anoikis, a process of programmed cell death that occurs when cells detach from the extracellular matrix, is closely associated with tumor invasion and m...

Full description

Saved in:
Bibliographic Details
Main Authors: Ziyi Zhou, Lanlan Yang, Yuan Fang, Rongzhong Xu, Xi Wang, Yuli Wang, Zhihong Fang
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-88882-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862282251141120
author Ziyi Zhou
Lanlan Yang
Yuan Fang
Rongzhong Xu
Xi Wang
Yuli Wang
Zhihong Fang
author_facet Ziyi Zhou
Lanlan Yang
Yuan Fang
Rongzhong Xu
Xi Wang
Yuli Wang
Zhihong Fang
author_sort Ziyi Zhou
collection DOAJ
description Abstract Stomach adenocarcinoma (STAD) is the most prevalent gastrointestinal malignancy and seriously threatens the life of the global population. Anoikis, a process of programmed cell death that occurs when cells detach from the extracellular matrix, is closely associated with tumor invasion and metastasis. In this study, we used the TCGA-STAD database to identify the expression patterns and prognostic relevance of anoikis-related genes (ARGs) in STAD. Functional enrichment analysis was used to explore the potential pathway. LASSO and Cox regression were used to construct anoikis-related prognostic signature. The anoikis risk score (ARS) incorporated 7 genes and stratified patients into highand low-risk subgroups by median value splitting. In addition, external validation was performed based on GSE66229, GSE15459, and GSE84437 cohorts. Nomograms were created based on risk characteristics in combination with clinical variants and the performance of the model was validated with time-dependent AUC, calibration curves, and decision curve analysis (DCA). The prognostic signature indicated that the low-risk subgroup had better outcomes and significant correlations with tumor microenvironment, immune landscape, immunotherapy response, and drug sensitivity. In addition, single-cell analysis displayed the cell types, the subcellular localization of prognostic genes, and the cellular interaction to reveal the potential molecular communication mechanism of anoikis resistance. Finally, in vitro experiments confirmed the critical role of CRABP2 in STAD. The results indicated that CRABP2 knockdown inhibited gastric cancer cell proliferation, migration and invasion, and promoted apoptosis. In summary, ARS can serve as a biomarker for predicting survival outcomes in STAD patients, providing new tools for personalized treatment decisions for STAD patients.
format Article
id doaj-art-1e051bac88c04d7c9363ed89370294e6
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-1e051bac88c04d7c9363ed89370294e62025-02-09T12:35:11ZengNature PortfolioScientific Reports2045-23222025-02-0115112010.1038/s41598-025-88882-9Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinomaZiyi Zhou0Lanlan Yang1Yuan Fang2Rongzhong Xu3Xi Wang4Yuli Wang5Zhihong Fang6Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese MedicineClinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese MedicineClinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese MedicineClinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese MedicineClinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese MedicineClinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese MedicineClinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese MedicineAbstract Stomach adenocarcinoma (STAD) is the most prevalent gastrointestinal malignancy and seriously threatens the life of the global population. Anoikis, a process of programmed cell death that occurs when cells detach from the extracellular matrix, is closely associated with tumor invasion and metastasis. In this study, we used the TCGA-STAD database to identify the expression patterns and prognostic relevance of anoikis-related genes (ARGs) in STAD. Functional enrichment analysis was used to explore the potential pathway. LASSO and Cox regression were used to construct anoikis-related prognostic signature. The anoikis risk score (ARS) incorporated 7 genes and stratified patients into highand low-risk subgroups by median value splitting. In addition, external validation was performed based on GSE66229, GSE15459, and GSE84437 cohorts. Nomograms were created based on risk characteristics in combination with clinical variants and the performance of the model was validated with time-dependent AUC, calibration curves, and decision curve analysis (DCA). The prognostic signature indicated that the low-risk subgroup had better outcomes and significant correlations with tumor microenvironment, immune landscape, immunotherapy response, and drug sensitivity. In addition, single-cell analysis displayed the cell types, the subcellular localization of prognostic genes, and the cellular interaction to reveal the potential molecular communication mechanism of anoikis resistance. Finally, in vitro experiments confirmed the critical role of CRABP2 in STAD. The results indicated that CRABP2 knockdown inhibited gastric cancer cell proliferation, migration and invasion, and promoted apoptosis. In summary, ARS can serve as a biomarker for predicting survival outcomes in STAD patients, providing new tools for personalized treatment decisions for STAD patients.https://doi.org/10.1038/s41598-025-88882-9BioinformaticsStomach adenocarcinomaAnoikisTumor microenvironmentImmune landscape
spellingShingle Ziyi Zhou
Lanlan Yang
Yuan Fang
Rongzhong Xu
Xi Wang
Yuli Wang
Zhihong Fang
Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
Scientific Reports
Bioinformatics
Stomach adenocarcinoma
Anoikis
Tumor microenvironment
Immune landscape
title Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
title_full Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
title_fullStr Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
title_full_unstemmed Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
title_short Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
title_sort integrative analysis of anoikis related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
topic Bioinformatics
Stomach adenocarcinoma
Anoikis
Tumor microenvironment
Immune landscape
url https://doi.org/10.1038/s41598-025-88882-9
work_keys_str_mv AT ziyizhou integrativeanalysisofanoikisrelatedprognosticsignaturetoevaluatetheimmunelandscapeandpredicttherapeuticresponseinstomachadenocarcinoma
AT lanlanyang integrativeanalysisofanoikisrelatedprognosticsignaturetoevaluatetheimmunelandscapeandpredicttherapeuticresponseinstomachadenocarcinoma
AT yuanfang integrativeanalysisofanoikisrelatedprognosticsignaturetoevaluatetheimmunelandscapeandpredicttherapeuticresponseinstomachadenocarcinoma
AT rongzhongxu integrativeanalysisofanoikisrelatedprognosticsignaturetoevaluatetheimmunelandscapeandpredicttherapeuticresponseinstomachadenocarcinoma
AT xiwang integrativeanalysisofanoikisrelatedprognosticsignaturetoevaluatetheimmunelandscapeandpredicttherapeuticresponseinstomachadenocarcinoma
AT yuliwang integrativeanalysisofanoikisrelatedprognosticsignaturetoevaluatetheimmunelandscapeandpredicttherapeuticresponseinstomachadenocarcinoma
AT zhihongfang integrativeanalysisofanoikisrelatedprognosticsignaturetoevaluatetheimmunelandscapeandpredicttherapeuticresponseinstomachadenocarcinoma